Perspectives in the molecular mechanisms of antidepressant action
Costa, E.
Advances in Biochemical Psychopharmacology 31: 21-26
1982
ISSN/ISBN: 0065-2229 PMID: 6123223 Document Number: 190918
Document emailed within 1 workday
Related Documents
Youle, R J. 2003: Haya Lorberboum-Galski and Philip Lazarovici (Eds.). Chimeric Toxins: Mechanisms of Action and Therapeutic Applications (Cell and Molecular Mechanisms of Toxin Action) International Journal of Toxicology 22(4): 331-332Kovalev, D.G.; Zimin, I.A.; Smirnova, L.A.; Riabukha, A.F. 2010: Neurochemical mechanisms of antidepressant action of new adenine derivative Eksperimental'naia i Klinicheskaia Farmakologiia 73(12): 13-16
Coquoz, D.; Porchet, H.C.; Dayer, P. 1991: Central analgesic effects of antidepressant drugs with various mechanisms of action: desipramine, fluvoxamine and moclobemide Schweizerische Medizinische Wochenschrift 121(49): 1843-1845
Shirinskiĭ, V.P.; Khapchaev, A.I.; Stepanova, O.V. 2008: Molecular mechanisms of cardiomyogenesis and perspectives of cardiomyocyte regeneration in cardiac failure Molekuliarnaia Biologiia 42(5): 856-866
Gauze, G.F.; Dudnik, I.V. 1979: Molecular mechanisms of the action of anticancer antibiotics Vestnik Akademii Meditsinskikh Nauk SSSR 1979(8): 73-79
Zhang, X.K.; Pfahl, M. 1994: Molecular mechanisms of action for vitamin A-derived hormones Progress in Clinical and Biological Research 387: 59-71
Fuks, B.B.; Sterlina, A.G. 1985: Study of the molecular and cellular mechanisms of action of lipid immunomodulators Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 9: 38-43
Narahashi, T. 1982: Cellular and molecular mechanisms of action of insecticides: neurophysiological approach Neurobehavioral Toxicology and Teratology 4(6): 753-758
Gauze, G.F.; Dudnik, I.V. 1982: Study of molecular mechanisms of action and the use of antineoplastic antibiotics in the USSR Antibiotiki 27(12): 9-18
Wustrow, T.P. 1991: Interactions and biological mechanisms of action of molecular signal peptides. II. Interleukin 2 (IL-2) Hno 39(9): 323-331
Korotkina, R.N.; Fomchenkov, E.P.; Andreev, V.I.; Smirnova, V.I.; Karelin, A.A. 1992: Molecular mechanisms of antioxidant action of dalargin on the liver in experimental cholestasis Biulleten' Eksperimental'noi Biologii i Meditsiny 113(1): 38-40
Manji, H.K.; Moore, G.J.; Chen, G. 2001: Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers British Journal of Psychiatry. Suppl 41: S107-S119
Shibata, H. 2015: Action mechanisms of molecular target agents and their off-target toxicities; introduction Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 2): 198-203
Nowak, G.; Szewczyk, B. 2002: Mechanisms contributing to antidepressant zinc actions Polish Journal of Pharmacology 54(6): 587-592
Novotný, P. 1973: An antihistaminic with antidepressant action Casopis Lekaru Ceskych 112(41): 1276-1277
Sheikh, S.P.; Carisen, J.; Hansen, P.R.; Haunsø, S. 1997: Molecular biology and cardiology. Molecular mechanisms in heart failure Ugeskrift for Laeger 159(17): 2523-2528
Vetulani, J. 1989: The development of understanding of the mechanism of action of antidepressant drugs Activitas Nervosa Superior 31(1): 24-25
Eroğlu, L.; Hizal, A. 1987: Antidepressant action of lithium in behavioral despair test Polish Journal of Pharmacology and Pharmacy 39(6): 667-673
Maj, J. 1987: Pharmacological profile and mechanism of action of antidepressant drugs Acta Physiologica Polonica 38(4): 289-301
Benesová, O. 1970: Neurophysiological and biochemical aspects in the action of antidepressant drugs Activitas Nervosa Superior 12(3): 226-234